Onzima Ventures to buy remaining stake in drug discovery company

Maryam Cockar WebFG News | 13 Apr, 2017 09:11 | | |

pills tablets medicine drugs pharmaceutical
  • 8.25
  • 4.76%0.38
  • Max: 8.75
  • Min: 7.75
  • Volume: 1,151,098
  • MM 200 : n/a
17:18 17/11/17
  • 2,405.48
  • -0.45%-10.88
  • Max: 2,420.60
  • Min: 2,392.08
  • Volume: 0
  • MM 200 : n/a
17:18 17/11/17
  • 1,023.43
  • 0.18%1.82
  • Max: 1,023.88
  • Min: 1,021.32
  • Volume: 0
  • MM 200 : n/a
17:25 17/11/17

AIM-listed investor Onzima Ventures is to buy the remaining 51% stake it does not already own in N4 Pharma, a drug discovery company, subject to shareholder approval.

At the next general meeting on 2 May, the company will also propose change its name to N4 Pharma, and if approved its ticker will be changed to N4P and its website address to www.n4pharma.com.

The company will pay for the interest with issue of 4.51m new shares and 4,59m deferred shares to be issued after the reorganisation of its shares. The new shares expected to trade on AIM on 3 May.

Onzima has also raised £1.5m from a placing of 21.42m shares at 7p each to fund development of additional patent applications for reformulations of a range of generic drugs, to undertake clinical trials for N4 Pharma's reformulation of sildenafil, the medical name for generic Viagra.

N4 Pharma chief executive Nigel Theobald said: "Bringing a new drug to market is inherently risky, time consuming and extremely costly. However, the established process of reformulating already established drugs reduces the risk, cost and length of time it takes to bring new versions of these drugs to market.

“Following completion of the transaction, the net funds raised will enable N4 Pharma to accelerate its work on the reformulation of generic drugs and those that are coming to the end of their patent protection, each with attractive commercial opportunities, as well as expand our product portfolio.”

More news

17 Nov Europe close: Stocks slip going into the weekend

Stocks reversed early gains as investors opted to play it safe going into the weekend and the euro edged a tad higher on the back of the political gyrations on Capitol Hill.

17 Nov Europe open: Stocks start slightly higher, analysts wary

Stocks have started the morning trading slightly higher, tracking overnight gains on Wall Street but analysts are worried about buying into Thursday's bounce.

17 Nov London close: Stocks finish week on down note

London's top flight index slipped on Friday, but managed to finish well-off its lows of the session despite renewed Brexit angst as the pound gave back early gains.

17 Nov Kingfisher gets RBC upgrade as 'reasons to be cheerful' in France

DIY retailer Kingfisher has more "reasons to be cheerful" thanks to an improving French outlook, analysts at RBC Capital Markets said on Friday, while clothes seller Supergroup remains "compelling" but its shares have gained a lot in recent weeks.

17 Nov NAV on the rise as Alpha Real Estate Trust turns focus to build-to-rent market

Real estate investment group Alpha Real Trust saw its net asset value (NAV) rise in its first half of trading as it moved to make further investments in build-to-rent projects.

17 Nov Pacific Industrial & Logistics completes sale of Bedford asset

Industrial and logistics-focussed real estate investment trust Pacific Industrial & Logistics has completed the sale of an asset located at Hammond Road, Bedford, for a total consideration of £5.8m, it announced on Friday.

17 Nov DP Poland cuts ribbon on 50th Polish Domino's store

DP Poland, which holds the exclusive master franchise for the Domino’s Pizza brand in Poland, celebrated the opening of its 50th location in the country on Friday.

17 Nov Mercia Technologies makes new investment into Aston EyeTech

National investment group Mercia Technologies has made a new direct investment into Aston EyeTech - a spinout from Aston University, Birmingham - which has developed a range of proprietary hardware and software products in ocular care, it announced on Friday.

17 Nov SimiGon receives final approval for $2m Israeli Air Force order

Modelling, simulation and training solutions provider SimiGon has now received final regulatory approval for a $2m purchase order received from the Israeli Air Force, initially announced on 20 June 2016, it confirmed on Friday.

17 Nov Agriterra losses grow after 'subdued' interest in corn products

Agricultural investment group Agriterra saw losses widen in the first half of its trading year as subdued demand for its maize flour products slashed revenues by more than a third.